 | Up a level |
Journal Article
Jawhar, M., Naumann, N., Knut, M., Schneider, B., Ghazzawi, M., Kreuzer, K-A., Hallek, M., Fabarius, A., Score, J., Chase, A., Tapper, W., Reiter, A. and Cross, N. (2017). ZMYM2-FLT3 IS A RARE, RECURRENT, CYTOGENTICALLY CRYPTIC FUSION IN MYELOID/LYMPHOID NEOPLASMS WITH EOSINOPHILIA THAT IS RESPONSIVE TO FLT3 INHIBITION. Haematologica, 102. S. 553 - 554. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Jawhar, M., Naumann, N., Knut, M., Score, J., Ghazzawi, M., Schneider, B., Kreuzer, K-A, Hallek, M., Drexler, H. G., Chacko, J., Wallis, L., Fabarius, A., Metzgeroth, G., Hofmann, W-K, Chase, A., Tapper, W., Reiter, A. and Cross, N. C. P. (2017). Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia. Leukemia, 31 (10). S. 2271 - 2275. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Jawhar, M., Naumann, N., Knut, M., Score, J., Ghazzawi, M., Schneider, B., Kreuzer, K. -A., Hallek, M., Chacko, J., Wallis, L., Schwaab, J., Metzgeroth, G., Hofmann, W. -K., Fabarius, A., Chase, A., Tapper, W., Cross, N. C. P. and Reiter, A. (2017). Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasm with eosinophilia. Oncol. Res. Treat., 40. S. 150 - 151. BASEL: KARGER. ISSN 2296-5262
Jawharl, M., Naumann, N., Schwaab, J., Dietz, C., Casper, J., Dang, T. A., Dietze, L., Doehner, K., Haenel, A., Lathan, B., Link, H., Lotfti, S., Mielkel, S., Luber, V., Maywald, O., Mueller, L., Platzbecker, U., Pruemmer, O., Thomssen, H., Toepelt, K., Schmitt, K., Baurmann, H., Vielert, T., Hofmann, W. K., Haferlach, C., Cross, N. C., Fabarius, A., Reiter, A. and Metzgeroth, G. (2016). CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME ON IMATINIB IN PATIENTS WITH MYELOID/LYMPHOID NEOPLASMS AND ASSOCIATED PDGFRB FUSION GENES IN CHRONIC OR BLAST PHASE. Haematologica, 101. S. 264 - 266. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078